Bioshares Report stated"to date no serious adverse events related to the treatment have been reported in the ANP Phase 2 trial.If the trial results are good then ANP will activate licensing discussions with potential partners"
This report was released just after the Interim results re Acromegaly.
Well here we are.as many have said that anp already have the report.
Pfizer will protect their market share.(somavert)
I cannot see Anp selling the whole company for under a $1.
- Forums
- ASX - By Stock
- Anp Take Over price.
Bioshares Report stated"to date no serious adverse events...
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.92M |
Open | High | Low | Value | Volume |
8.0¢ | 8.2¢ | 8.0¢ | $111.7K | 1.386M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31160 | 8.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 21976 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 31160 | 0.081 |
1 | 42922 | 0.080 |
1 | 25278 | 0.079 |
2 | 30620 | 0.078 |
1 | 10000 | 0.077 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 21976 | 1 |
0.083 | 100000 | 1 |
0.084 | 160250 | 2 |
0.085 | 168500 | 2 |
0.086 | 291111 | 3 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online